GlassScriptPhysician profile
Antonio P Giannelli
NPI 1841369642
$21,645.00
in general payments reported to CMS, 2019-2025
36 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,829 · 2022: $5,531 · 2023: $5,032 · 2024: $5,152 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,901.95 |
| Education | $382.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $4,573.63 | 2021-2025 | Tremfya, Simponi Aria |
| Amgen INC. | $3,851.61 | 2021-2025 | Otezla, Enbrel, Evenity |
| Abbvie INC. | $2,732.77 | 2021-2025 | |
| Ucb, INC. | $2,423.87 | 2021-2025 | Cimzia, Bimzelx |
| Astrazeneca Pharmaceuticals LP | $1,285.34 | 2021-2025 | Saphnelo |
| Novartis Pharmaceuticals Corporation | $1,036.62 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $844.98 | 2021-2025 | Acthar |
| Lilly USA, LLC | $542.95 | 2021-2024 | Taltz |
| Pfizer INC. | $461.40 | 2021-2024 | |
| Ani Pharmaceuticals, INC. | $421.24 | 2022-2024 | Purified Cortrophin Gel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $402.21 | 2021-2024 | Ofev |
| Aurinia Pharma U.S., INC. | $377.06 | 2021-2023 | Lupkynis |
| E.R. Squibb & Sons, L.L.C. | $367.93 | 2021-2024 | Orencia |
| Horizon Therapeutics Plc | $357.67 | 2021-2023 | Krystexxa |
| Alexion Pharmaceuticals, INC. | $286.26 | 2021-2025 | Strensiq, Ultomiris |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $234.45 | 2021-2025 | |
| Glaxosmithkline, LLC. | $210.31 | 2021-2023 | Nucala, Benlysta |
| Organon LLC | $204.21 | 2023-2024 | Renflexis, Hadlima |
| Kiniksa Pharmaceuticals International, Plc | $148.73 | 2024 | Arcalyst |
| Janssen Scientific Affairs, LLC | $139.74 | 2021-2025 | Tremfya |
| Fresenius Kabi USA, LLC | $122.63 | 2023-2025 | Idacio |
| Genentech USA, INC. | $115.50 | 2021-2024 | Actemra |
| Merck Sharp & Dohme LLC | $73.79 | 2022-2024 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Sobi, INC | $60.73 | 2022-2024 | |
| Sandoz INC. | $56.05 | 2023-2024 | Hyrimoz |
| Fidia Pharma USA INC. | $55.90 | 2022 | |
| Daiichi Sankyo INC. | $53.09 | 2022-2023 | Injectafer |
| Kyowa Kirin, INC. | $37.71 | 2023-2024 | Crysvita |
| United Therapeutics Corporation | $32.23 | 2024 | Tyvaso |
| Alvogen INC | $30.28 | 2024 | Teriparatide |
| Boston Scientific Corporation | $24.61 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.40 | 2024 | Hyqvia |
| Radius Health, INC. | $15.31 | 2024 | Tymlos |
| Hospira, INC. | $14.21 | 2024 | |
| Bioventus LLC | $13.63 | 2022 | |
| Alnylam Pharmaceuticals INC. | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Giannelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.